(Q34093594)

31 July 2017

title

Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors (English)

1 reference

31 July 2017

7

David R Grattan

1 reference

31 July 2017

9

John J Kopchick

1 reference

31 July 2017

8

Bruce Kelder

1 reference

31 July 2017

Vincent Rouet

1

1 reference

31 July 2017

Roman L Bogorad

2

1 reference

31 July 2017

Christine Kayser

3

1 reference

31 July 2017

Karima Kessal

4

1 reference

31 July 2017

Catherine Genestie

5

1 reference

31 July 2017

Armelle Bardier

6

1 reference

31 July 2017

Paul A Kelly

10

1 reference

31 July 2017

Vincent Goffin

11

1 reference

31 July 2017

language of work or name

English

0 references

publication date

9 August 2010

1 reference

Proceedings of the National Academy of Sciences of the United States of America

31 July 2017

published in

1 reference

31 July 2017

volume

107

1 reference

31 July 2017

issue

34

1 reference

31 July 2017

page(s)

15199-15204

1 reference

Basal epithelial stem cells are efficient targets for prostate cancer initiation

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Understanding the epidemiology, natural history, and key pathways involved in prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Identification of a gain-of-function mutation of the prolactin receptor in women with benign breast tumors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Prostate cancer stem cells: a new target for therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Transcription factor signal transducer and activator of transcription 5 promotes growth of human prostate cancer cells in vivo

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Stem cells in prostate cancer initiation and progression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Autocrine prolactin promotes prostate cancer cell growth via Janus kinase-2-signal transducer and activator of transcription-5a/b signaling pathway

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Pten deletion leads to the expansion of a prostatic stem/progenitor cell subpopulation and tumor initiation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Development and potential clinical uses of human prolactin receptor antagonists

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Prostate epithelial cell differentiation and its relevance to the understanding of prostate cancer therapies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Prostate pathology of genetically engineered mice: definitions and classification. The consensus report from the Bar Harbor meeting of the Mouse Models of Human Cancer Consortium Prostate Pathology Committee.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Gene expression analysis of prostate hyperplasia in mice overexpressing the prolactin gene specifically in the prostate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Prostate development and carcinogenesis in prolactin receptor knockout mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Prostatic intraepithelial neoplasia in genetically engineered mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

PRL signal transduction in the epithelial compartment of rat prostate maintained as long-term organ cultures in vitro

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

p63 is a prostate basal cell marker and is required for prostate development

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

Prolactin and prolactin receptors are expressed and functioning in human prostate

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930529

In vivo response-based identification of direct hormone target cell populations using high-density tissue arrays.

5 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0911651107

Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0911651107

Development of pure prolactin receptor antagonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0911651107

Spontaneous lesions in control B6C3F1 mice and recommended sectioning of male accessory sex organs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0911651107

Activation of signal transducer and activator of transcription 5 in human prostate cancer is associated with high histological grade

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20699217

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Activation of signal transducer and activator of transcription-5 in prostate cancer predicts early recurrence

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20699217

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1073/PNAS.0911651107

1 reference

31 July 2017

0 references

1 reference

31 July 2017

1 reference